Back to today’s briefing

Story perspectives

Thermo Fisher to Acquire Solventum for $4.1 Billion

2/26/2025

27 2

Summary

Story summary

Thermo Fisher Scientific is set to acquire Solventum’s Purification & Filtration business for a staggering $4.1 billion. With 2,500 employees and $1 billion in revenue in 2024, this strategic move, expected to finalize by late 2025, will significantly bolster Thermo Fisher's bioprocessing prowess and propel its expansion in biologic drug manufacturing.

History

Historical Context

Thermo Fisher Scientific's $4.1 billion acquisition of Solventum's Purification & Filtration business echoes its historical strategy of growth through mergers. Since its formation in 2006, Thermo Fisher has consistently expanded its capabilities, similar to its past acquisitions like Life Technologies in 2013, enhancing its market position in bioprocessing.

1 of 2

Story summary

Thermo Fisher Scientific is set to acquire Solventum’s Purification & Filtration business for a staggering $4.1 billion. With 2,500 employees and $1 billion in revenue in 2024, this strategic move, expected to finalize by late 2025, will significantly bolster Thermo Fisher's bioprocessing prowess and propel its expansion in biologic drug manufacturing.

1 / 2